Download the Agenda


Speaker Information

Prof. Gal Markel
Prof. Gal Markel Chief Scientist Ella Institute of Melanoma Sheba Medical Center


Main Conference Day 2

9:10 AM KEYNOTE ADDRESS: Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms

•    Hear about the Sheba Medical Centre’s experience with anti-melanoma immunotherapies, specifically with metastatic melanoma, a highly immunogenic tumor
•    Discover how and why the FDA approved Ipilimumab for metastatic melanomas
•    Learn about new immunomodulatory approaches currently in the development pipeline, with a focus on the novel CEACAM1 immune checkpoint
•    This talk combines multi-disciplinary approaches and describes anti-melanoma immunotherapies from molecular, medical, and business angles

Sponsorship Opportunities

Resource Center

Visit the Resource Center for complimentary industry related content!

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!